The ability to quantify differentiation potential of single cells is a task of critical 18 importance for single-cell studies. So far however, there is no robust general molecular 19 correlate of differentiation potential at the single cell level. Here we show that 20 differentiation potency of a single cell can be approximated by computing the signaling 21 promiscuity, or entropy, of a cell's transcriptomic profile in the context of a cellular 22 interaction network, without the need for model training or feature selection. We 23 validate signaling entropy in over 7,000 single cell RNA-Seq profiles, representing all 24 main differentiation stages, including time-course data. We develop a novel algorithm 25 called Single Cell Entropy (SCENT), which correctly identifies known cell 26 subpopulations of varying potency, enabling reconstruction of cell-lineage trajectories. 27 By comparing bulk to single cell data, SCENT reveals that expression heterogeneity 28 within single cell populations is regulated, pointing towards the importance of cell-cell 29 interactions. In the context of cancer, SCENT can identify drug resistant cancer 30 stem-cell phenotypes, including those obtained from circulating tumor cells. In 31 summary, SCENT can directly estimate the differentiation potency and plasticity of 32 single-cells, allowing unbiased quantification of intercellular heterogeneity, and 33 providing a means to identify normal and cancer stem cell phenotypes. 34 35 Software Availability: SCENT is freely available as an R-package from github: 37 https://github.com/aet21/SCENT 38 39 40 One of the most important tasks in single-cell RNA-sequencing studies is the identification 41 and quantification of intercellular transcriptomic heterogeneity [1-4]. Although some of the 42 observed heterogeneity represents stochastic noise, a substantial component of intercellular 43 variation has been shown to be of functional importance [1, 5-8]. Very often, this biologically 44 relevant heterogeneity can be attributed to cells occupying states of different potency or 45 plasticity. Thus, quantification of differentiation potency, or more generally functional 46 plasticity, at the single-cell level is of paramount importance. However, currently there is no 47 concrete theoretical and computational model for estimating such plasticity at the single cell 48 level.
6 the G1-S or G2-M phase (SI fig.S5 ). In contrast, cells with high signaling entropy could be 169 found in either a cycling or non-cycling phase. These results are consistent with the view that 170 cycling-cells must increase expression of promiscuous signaling proteins and hence exhibit 171 an increased signaling entropy.
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Quantification of inter-cellular expression heterogeneity with SCENT 174 Given that signaling entropy correlates with differentiation potency, we used it to develop the 175 SCENT algorithm (Fig.1C) . Briefly, the SCENT algorithm uses the estimated signaling 176 entropies of single cells to derive the distribution of discrete potency states across the cell 177 population (Fig.1C, Online Methods) . Thus, SCENT can be used to quantify expression 178 heterogeneity at the level of potency. In addition, SCENT can be used to directly order single 179 cells in pseudo-time [14] to facilitate reconstruction of lineage trajectories. A key feature of 180 SCENT is the assignment of each cell to a unique potency state and co-expression cluster, 181 which results in the identification of potency-clusters (which we call "landmarks"), through 182 which lineage trajectories are then inferred (Online Methods). 183 To test SCENT, we applied it to the scRNA-Seq data from Chu et al, a non-time course 184 single-cell experiment, which includes hESCs and progenitor cell populations (SI table S1). 185 SCENT correctly predicted a parsimonious two potency state model, with a high potency 186 pluripotent state and a lower potency non-pluripotent progenitor-like state (Fig.3A) . 187 Interestingly, a small fraction (approximately 4%) of the single hESCs were deemed to be 188 non-pluripotent cells (Fig.3B ), consistent with previous observations that pluripotent cell 189 populations contain cells that are already primed for differentiation into specific lineages [5, non-pluripotent cells (Fig.3B) . Correspondingly, the Shannon index, which quantifies the 196 level of heterogeneity in potency, was highest for the NPC population (Fig.3C ). In total, 197 SCENT predicted 6 co-expression clusters, which combined with the two potency states, 198 resulted in a total of 7 landmark clusters (Fig.3D ). These landmarks correlated very strongly 199 with cell-type, with only NPCs being distributed across two landmarks of different potency 200 ( Fig.3E) . SCENT correctly inferred a lineage trajectory between the high potency NPC 201 subpopulation and its lower potency counterpart, as well as a trajectory between hESCs and 202 DEPs (Fig.3F ). The other cell-types exhibited lower entropies ( Fig.2B & Fig.3F) , and 203 correspondingly did not exhibit a direct trajectory to hESCs, suggesting several intermediate 204 states which were not sampled in this experiment. 205 To ascertain the biological significance of the two NPC subpopulations (Fig.3B ,E,F), we first 206 verified that the NPCs deemed pluripotent did indeed have a higher pluripotency score (SI 207 7 fig.7A ), as assessed using the independent pluripotency gene expression signature from 208 Palmer et al [21] . We further reasoned that well-known transcription factors marking neural 209 stem/progenitor cells, such as HES1, would be expressed at a much lower level in the NPCs 210 deemed pluripotent compared to the non-pluripotent ones, since the latter are more likely to 211 represent bona-fide NPCs. Confirming this, NPCs with low HES1 expression exhibited 212 higher differentiation potential than NPCs with high HES1 expression (Wilcoxon rank sum 213 test P<0.0001, Fig.3G ). Similar results were evident for other neural progenitor/stem cell 214 markers such as PAX6 and SOX2 (SI fig.S7B ). Of note, NPCs expressing the lowest levels of 215 PAX6, HES1 or SOX2 were generally always classified by SCENT into a pluripotent-like 216 state ( Fig.3G, SI fig.S7B ). Thus, these results indicate that SCENT provides a biologically 217 meaningful characterization of intercellular transcriptomic heterogeneity. 221 We next tested SCENT in the context of a differentiation experiment of human myoblasts
SCENT reconstructs lineage trajectories of human myoblast differentiation
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[14], involving skeletal muscle myoblasts which were first expanded under high mitogen 223 conditions and later induced to differentiate by switching to a low serum medium (Trapnell et   224 al set, SI table S1). A total of 96 cells were profiled with RNA-Seq at differentiation 225 induction, as well as at 24h and 48h after medium switch, with a remaining 84 cells profiled 226 at 72h. As expected, signaling entropy was highest in the myoblasts, with a stepwise Fig.4D ), suggesting that 240 these are "contaminating" interstitial mesenchymal cells that were already present at the start 241 of the time course, in line with previous observations [14, 15] . Importantly, SCENT correctly 242 predicts that the potency of all these mesenchymal cells in this landmark does not change 243 during the time-course, consistent with the fact that these cells are not primed to differentiate 244 into skeletal muscle cells, but which nevertheless aid the differentiation process [14, 15] . relapsed sample, scRNA-Seq for 96 single AML cells was available (AML set, SI table S1). 276 We posited that comparing the signaling entropy values of these 96 cells would allow us to 277 identify a CSC-like subset responsible for relapse. Since in AML there are well accepted CSC 278 markers (CD34, CD96), we tested whether expression of these markers in high entropy AML 279 single cells is higher than in low entropy AML single cells ( Fig.5D ). Both CD34 and CD96 280 were more highly expressed in the high entropy AML single cells (Wilcox test P=0.008 and 281 0.032, respectively, Fig.5D ). 282 We next computed signaling entropies for 73 circulating tumor cells (CTCs) derived from 11 283 castration resistant prostate cancer patients (CTC-PrCa set, SI table S1), of which 5 patients 284 exhibited progression under treatment with enzalutamide (an androgen receptor (AR) 
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In order to obtain further evidence for regulated heterogeneity, we note that matched bulk 315 RNA-Seq data is not absolutely required since bulk samples can be approximated by to be proportional to the normalized expression levels of the coding genes in the sample, i.e. 463 we assume that w gh ~ x g x h . We interpret these weights (if normalized) as interaction 464 probabilities. The above construction of the weights is based on the assumption that in a 465 sample with high expression of g and h, that the two proteins are more likely to interact than 466 in a sample with low expression of g and/or h. Viewing the edges generally as signaling 467 interactions, we can thus define a random walk on the network, assuming we normalize the 468 weights so that the sum of outgoing weights of a given node i is 1. This results in a stochastic where π is the invariant measure, satisfying πP=π and the normalization constraint π T 1=1. 474 Assuming detailed balance, it can be shown that = ( ) /(x T Ax). Given a fixed (SR/(1-SR) ). Subsequently, we fit a mixture of Gaussians to the To identify single cells in either the G1-S or G2-M phases of the cell-cycle we followed the 543 procedure described in [22] . Briefly, genes whose expression is reflective of G1-S or G2-M 544 phase were obtained from [29, 30] . A given normalized scRNA-Seq data matrix is then obtained by comparing expression z-scores. However, we note that the z-score procedure 555 uses information from all single cells, so the fairest comparison to signaling entropy means 556 we ought to compare expression levels. We note that the TPSC scores obtained from z-scores 557 or expression levels were highly correlated and did not affect any of the conclusions in this 558 manuscript. 
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